Corbion 과거 순이익 실적
과거 기준 점검 4/6
Corbion의 수입은 연평균 -11.1%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 12.2% 감소했습니다. 매출은 연평균 4.5%의 비율로 증가해 왔습니다. Corbion의 자기자본이익률은 10.1%이고 순이익률은 5.9%입니다.
핵심 정보
-11.08%
순이익 성장률
-10.79%
주당순이익(EPS) 성장률
| Chemicals 산업 성장률 | 1.60% |
| 매출 성장률 | 4.46% |
| 자기자본이익률 | 10.07% |
| 순이익률 | 5.90% |
| 다음 순이익 업데이트 | 31 Jul 2026 |
최근 과거 실적 업데이트
Recent updates
내러티브 업데이트 • Jun 01
CRBN: Special Dividend And Steady Guidance Will Support Future Re Rating
Analysts kept Corbion's fair value target steady at €28.00, citing modest adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions after the recent downgrade highlighted by Barclays. What's in the News Shareholders approved a total dividend of €1.00 per share for the 2025 financial year, including a special dividend of €0.36 per share, at the Annual General Shareholders Meeting on 13 May 2026.내러티브 업데이트 • May 09
CRBN: Special Dividend And Higher Future P E Could Support Re Rating
Analysts have reduced their fair value estimate for Corbion from €30.00 to €28.00, citing updated assumptions for revenue growth, profit margins and future P/E following recent research, including the Barclays downgrade. Analyst Commentary Recent research has led to a lower fair value estimate for Corbion, but bullish analysts still highlight several supports for the stock, focusing on how current assumptions around revenue, margins and P/E could play out over time.
내러티브 업데이트 • Apr 22
CRBN: Special Dividend And Execution On Margins Will Support Upside Potential
The updated analyst price target for Corbion has shifted slightly to about €24.03 from €24.17, as analysts adjust their assumptions around discount rate, revenue growth, profit margin and future P/E in light of recent research, including the Barclays downgrade. Analyst Commentary Bullish Takeaways Bullish analysts see the updated price target around €24.03 as still leaving some room for upside if Corbion executes well on its revenue and margin assumptions embedded in the models.
내러티브 업데이트 • Apr 08
CRBN: Raised Fair Value And Barclays Downgrade Will Shape Risk Balance
Analysts now set Corbion's fair value at €19.60, up from €18.60. This reflects updated assumptions on growth, margins and P/E multiples, even as some recent research, including a downgrade at Barclays, highlights ongoing risks.내러티브 업데이트 • Mar 24
CRBN: Higher Margins And Special Dividend Will Support Future Re Rating
Analysts have maintained their price target for Corbion at €30.00, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E as the main factors supporting the unchanged view. What's in the News Corbion N.V. proposed a special dividend of €0.36 per share, planned for distribution in 2025.내러티브 업데이트 • Mar 10
CRBN: Special Dividend And Stronger Margins Will Support A More Optimistic Outlook
Analysts have trimmed their price target on Corbion from €24.60 to about €24.17, reflecting updated views on its projected revenue growth, profit margins, and future P/E assumptions. What's in the News Corbion N.V. proposed a special dividend of €0.36 per share for 2025, which may influence your expected cash returns from holding the stock (Key Developments).내러티브 업데이트 • Feb 24
CRBN: Higher Future P/E Assumptions Will Support A More Optimistic Outlook
Analysts have raised their price target on Corbion from about €22.73 to €24.60, citing updated assumptions on discount rates, revenue growth, profit margins, and future P/E levels. Valuation Changes Fair Value: Updated estimate increased from about €22.73 to €24.60 per share.내러티브 업데이트 • Feb 09
CRBN: Buyback And Higher Discount Rate Will Pressure Overvalued Shares
Analysts have kept their price target on Corbion steady at €18.60, citing only small adjustments to assumptions around the discount rate, revenue trends, profit margins and future P/E as the basis for this unchanged view. What's in the News Corbion completed a share buyback program, repurchasing 577,615 shares for €10 million, equal to 0.99% of the company.내러티브 업데이트 • Jan 26
CRBN: Higher Future P/E And Execution Risks Will Shape EUR 18 Outlook
Narrative Update on Corbion Analysts have raised their fair value estimate for Corbion to €18.60 from €18.00. This reflects updated views on discount rates, long term revenue trends, profit margins, and a higher future P/E assumption, alongside recent Street research where a key price target moved to €18 from €16.50.분석 기사 • Jan 14
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), is not the largest company out there, but it saw a double-digit share price rise of over 10...내러티브 업데이트 • Jan 11
CRBN: Future P/E Reset And Margin Assumptions Will Shape EUR 18 Outlook
Analysts have raised their price target for Corbion to €18 from €16.50, citing updated assumptions on revenue trends, margins and future P/E as the main factors behind the change. Analyst Commentary The revised €18 price target still comes with a Hold stance, which signals a measured view on Corbion.내러티브 업데이트 • Dec 26
CRBN: Higher EUR 18 Outlook Will Test Margin Delivery Amid Muted Demand
Analysts have raised their fair value estimate for Corbion to EUR 18 from EUR 14, reflecting increased confidence in the company’s profit margin outlook and a willingness to apply a higher future earnings multiple despite more muted revenue growth expectations. Analyst Commentary Bearish analysts acknowledge the higher fair value estimate but continue to highlight a cautious stance on Corbion’s near term prospects, emphasizing that the improved target largely reflects valuation mechanics rather than a fundamental re-rating of the growth outlook.내러티브 업데이트 • Dec 12
CRBN: Margin Improvements And Buybacks Will Support A Future Re-Rating
Analysts have lowered their fair value price target on Corbion to EUR 30.00 from EUR 31.90, citing tempered expectations for long term revenue growth and profit margins, even as some recent Street research has modestly raised nearer term share price targets. Analyst Commentary Bullish analysts highlight that the recent upward revision in near term price targets, even from a relatively low base, reflects growing confidence that Corbion can stabilize its earnings profile and execute on margin improvement initiatives.분석 기사 • Nov 14
Corbion N.V. (AMS:CRBN) Shares Could Be 35% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €28.50 Current share price of...분석 기사 • Jun 23
Corbion N.V.'s (AMS:CRBN) Intrinsic Value Is Potentially 65% Above Its Share Price
Key Insights The projected fair value for Corbion is €30.72 based on 2 Stage Free Cash Flow to Equity Current share...분석 기사 • May 07
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
Key Insights Corbion's Annual General Meeting to take place on 14th of May Salary of €725.0k is part of CEO Olivier...분석 기사 • Apr 10
At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw significant share price movement during recent...분석 기사 • Mar 26
Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point
Corbion N.V.'s ( AMS:CRBN ) earnings announcement last week was disappointing for investors, despite the decent profit...
새로운 내러티브 • Mar 02
Expanding Into Natural Antioxidants And Efficiency Improvements Will Drive Future Success
Strategic initiatives and operational optimizations are expected to significantly enhance EBITDA margins and net margins.분석 기사 • Feb 28
Here's What To Make Of Corbion's (AMS:CRBN) Decelerating Rates Of Return
What are the early trends we should look for to identify a stock that could multiply in value over the long term...분석 기사 • Dec 18
Risks To Shareholder Returns Are Elevated At These Prices For Corbion N.V. (AMS:CRBN)
It's not a stretch to say that Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 15.8x right now seems...분석 기사 • Nov 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it received a lot of attention from a substantial price...분석 기사 • Oct 31
An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €31.60 Corbion's €23.28 share...분석 기사 • Sep 26
Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Jul 18
The Price Is Right For Corbion N.V. (AMS:CRBN)
It's not a stretch to say that Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 16.1x right now seems...분석 기사 • Jun 20
Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €25.18 Corbion is estimated to...분석 기사 • May 08
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
Key Insights Corbion will host its Annual General Meeting on 15th of May Salary of €713.0k is part of CEO Olivier...분석 기사 • Apr 17
Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Jan 20
Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking
There wouldn't be many who think Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 14.3x is worth a...분석 기사 • Dec 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw a decent share price growth in the teens level on...분석 기사 • Nov 04
Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €15.91 Corbion's €17.30 share...분석 기사 • Sep 13
Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...분석 기사 • Aug 04
Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...분석 기사 • Jul 14
When Should You Buy Corbion N.V. (AMS:CRBN)?
While Corbion N.V. ( AMS:CRBN ) might not be the most widely known stock at the moment, it received a lot of attention...분석 기사 • Jun 04
Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate
Key Insights The projected fair value for Corbion is €21.22 based on 2 Stage Free Cash Flow to Equity Current share...분석 기사 • Apr 21
Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Mar 10
Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56
Corbion N.V. ( AMS:CRBN ) has announced that it will pay a dividend of €0.56 per share on the 30th of May. The dividend...분석 기사 • Feb 22
Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?
Corbion N.V. ( AMS:CRBN ), is not the largest company out there, but it received a lot of attention from a substantial...분석 기사 • Jan 26
Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...분석 기사 • Dec 20
Is Corbion (AMS:CRBN) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...분석 기사 • Nov 24
Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Today we will run through one way of estimating the intrinsic value of Corbion N.V. ( AMS:CRBN ) by taking the expected...분석 기사 • Nov 09
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw a decent share price growth in the teens level on...매출 및 비용 세부 내역
매출 및 비용 세부 내역
Corbion가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Dec 25 | 1,267 | 75 | 174 | 43 |
| 30 Sep 25 | 1,282 | 70 | 178 | 44 |
| 30 Jun 25 | 1,297 | 66 | 182 | 45 |
| 31 Mar 25 | 1,292 | 56 | 182 | 45 |
| 31 Dec 24 | 1,288 | 46 | 183 | 46 |
| 30 Sep 24 | 1,274 | 48 | 180 | 46 |
| 30 Jun 24 | 1,260 | 50 | 177 | 45 |
| 31 Mar 24 | 1,262 | 47 | 176 | 45 |
| 31 Dec 23 | 1,264 | 43 | 176 | 46 |
| 30 Sep 23 | 1,338 | 48 | 178 | 47 |
| 30 Jun 23 | 1,412 | 54 | 180 | 48 |
| 31 Mar 23 | 1,435 | 72 | 176 | 48 |
| 31 Dec 22 | 1,458 | 90 | 171 | 47 |
| 30 Sep 22 | 1,350 | 76 | 167 | 46 |
| 30 Jun 22 | 1,243 | 63 | 162 | 46 |
| 31 Mar 22 | 1,157 | 70 | 158 | 44 |
| 31 Dec 21 | 1,071 | 78 | 155 | 43 |
| 30 Sep 21 | 1,040 | 97 | 149 | 41 |
| 30 Jun 21 | 1,010 | 116 | 144 | 40 |
| 31 Mar 21 | 998 | 95 | 142 | 38 |
| 31 Dec 20 | 987 | 73 | 140 | 37 |
| 30 Sep 20 | 992 | 49 | 143 | 35 |
| 30 Jun 20 | 997 | 24 | 147 | 32 |
| 31 Mar 20 | 987 | 25 | 147 | 33 |
| 31 Dec 19 | 976 | 26 | 146 | 35 |
| 30 Sep 19 | 953 | 37 | 141 | 38 |
| 30 Jun 19 | 930 | 48 | 135 | 42 |
| 31 Mar 19 | 914 | 51 | 132 | 41 |
| 31 Dec 18 | 897 | 54 | 129 | 39 |
| 30 Sep 18 | 883 | 61 | 128 | 37 |
| 30 Jun 18 | 869 | 69 | 126 | 35 |
| 31 Mar 18 | 880 | 77 | 126 | 34 |
| 31 Dec 17 | 892 | 85 | 126 | 33 |
| 30 Sep 17 | 905 | 87 | 128 | 32 |
| 30 Jun 17 | 918 | 89 | 130 | 32 |
| 31 Mar 17 | 914 | 95 | 128 | 31 |
| 31 Dec 16 | 911 | 102 | 126 | 31 |
| 30 Sep 16 | 917 | 103 | 124 | 33 |
| 30 Jun 16 | 922 | 104 | 122 | 34 |
| 31 Mar 16 | 920 | 91 | 122 | 33 |
| 31 Dec 15 | 918 | 78 | 121 | 33 |
| 30 Sep 15 | 885 | 45 | 119 | 32 |
| 30 Jun 15 | 851 | 13 | 118 | 31 |
양질의 수익: CRBN는 고품질 수익을 보유하고 있습니다.
이익 마진 증가: CRBN의 현재 순 이익률 (5.9%)은 지난해 (3.6%)보다 높습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: CRBN의 수익은 지난 5년 동안 연평균 11.1% 감소했습니다.
성장 가속화: 지난 1년간 CRBN 의 수익 증가율(63%)은 연간 평균(-11.1%)을 초과합니다.
수익 대 산업: CRBN의 지난 1년 수익 증가율(63%)은 Chemicals 업계의 32.3%를 상회했습니다.
자기자본이익률
높은 ROE: CRBN의 자본 수익률(10.1%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/06/09 09:25 |
| 종가 | 2026/06/09 00:00 |
| 수익 | 2025/12/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Corbion N.V.는 13명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Setu Sharda | Barclays |
| Sebastian Bray | Berenberg |
| Fintan Ryan | Berenberg |